No abstract available
MeSH terms
-
Arterial Occlusive Diseases / drug therapy*
-
Arterial Occlusive Diseases / metabolism
-
Aspirin / pharmacology
-
Aspirin / therapeutic use
-
Chronic Disease
-
Epoprostenol / biosynthesis
-
Fatty Acids, Monounsaturated / pharmacology
-
Fatty Acids, Monounsaturated / therapeutic use
-
Humans
-
Methacrylates / pharmacology
-
Methacrylates / therapeutic use
-
Polydeoxyribonucleotides / pharmacology
-
Polydeoxyribonucleotides / therapeutic use
-
Pyridines / pharmacology
-
Pyridines / therapeutic use
-
Thromboxane A2 / analogs & derivatives
-
Thromboxane A2 / biosynthesis
-
Thromboxane A2 / pharmacology
-
Thromboxane A2 / therapeutic use
-
Thromboxane-A Synthase / antagonists & inhibitors*
Substances
-
Fatty Acids, Monounsaturated
-
Methacrylates
-
Polydeoxyribonucleotides
-
Pyridines
-
defibrotide
-
Thromboxane A2
-
ONO 3708
-
Epoprostenol
-
Thromboxane-A Synthase
-
isbogrel
-
ozagrel
-
Aspirin